Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;69(1):25-30.
doi: 10.1007/s13224-017-1074-4. Epub 2017 Nov 15.

Neonatal Effects of Maternal Magnesium Sulphate in Late Preterm and Term Pregnancies

Arun Ambadkar  1 , Madhva Prasad  1 , Anahita R Chauhan  1
Affiliations

Neonatal Effects of Maternal Magnesium Sulphate in Late Preterm and Term Pregnancies

Arun Ambadkar et al. J Obstet Gynaecol India. 2019 Feb.

Abstract

Aim: To compare the clinical, obstetric and neonatal parameters between patients with > 34-week gestation having severe preeclampsia receiving magnesium sulphate and those with > 34-week gestation with preeclampsia but not receiving magnesium sulphate.

Materials and methods: Single-centre prospective study studied 60 patients in each of the two groups. Magnesium sulphate was administered by Pritchard regimen as per standard protocol. Standard obstetric management was followed for both groups. In the severe preeclampsia/eclampsia group, maternal blood sample was analysed for serum magnesium levels. The duration of exposure, the amount of magnesium sulphate received and time elapsed between last dose of magnesium sulphate and delivery were all noted. Neonatal assessment was done. The various parameters including age, parity, blood pressure, mode of termination of pregnancy, NICU admission rate, incidence of hypotonia in the newborn and other neonatal parameters were tabulated and compared.

Results: The two groups were comparable with respect to age and parity. Need for induction of labour was higher in the group with severe preeclampsia/eclampsia. Rate of LSCS and birth weights were comparable between the two groups. NICU admission rate and incidence of hypotonia were higher in those who received magnesium sulphate. Amount of magnesium sulphate received and total duration of magnesium sulphate did not correlate with NICU admission rates.

Conclusions: Neonatal morbidity, in terms of higher NICU admission rates and hypotonia, is higher in patients receiving magnesium sulphate.

Keywords: Hypotonia; Magnesium sulphate; NICU admission; Neonatal; Neuroprotection.

PubMed Disclaimer

Conflict of interest statement

All the authors declare that they have no conflict of interest.All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Since it was a retrospective review of records, no informed consent was obtained from any patients for being included in the study. This article does not contain any studies with animal subjects.

References

    1. Bain ES, Middleton PF, Crowther CA. Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review. BMC Pregnancy Childbirth. BioMed Central 2013;13:195. http://www.ncbi.nlm.nih.gov/pubmed/24139447. - PMC - PubMed
    1. Bain E, Bubner T, Ashwood P, et al. Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand. Aust N Z J Obstet Gynaecol. 2013;53(1):86–89. doi: 10.1111/ajo.12008. - DOI - PubMed
    1. Nguyen TMN, Crowther CA, Wilkinson D, et al. Magnesium sulphate for women at term for neuroprotection of the fetus. Cochrane Database Syst Rev. 2013 - PMC - PubMed
    1. Drinkwater J. Magnesium sulphate for pre-eclampsia: care of the neonate. Pract Midwife. 2011;14(11):17–19. - PubMed
    1. Greenberg MB, Penn AA, Thomas LJ et al. Neonatal medical admission in a term and late-preterm cohort exposed to magnesium sulfate. Am J Obstet Gynecol. 2011; 204(6):515.e1–515.e7. http://www.ncbi.nlm.nih.gov/pubmed/21376302. - PubMed

LinkOut - more resources